One of the most commonly mutated genes in non-small-cell lung cancer is nuclear factor erythroid 2-related factor 2 (NRF2), which drives oncogenic progression in this context in part by activating NQO1 transcription, thereby increasing superoxide scavenging33. Here, NFE2L2 is linked to non-small cell lung carcinoma.